Erika Ritter

5.5k citations

38 papers · 2.1k indexed · 1 hit paper · h-index 21

Impact in

Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research

Papers in

Immunology 27
- Immunotherapy and Immune Responses 25
- T-cell and B-cell Immunology 8
- Immune Cell Function and Interaction 7
Oncology 10
- Cancer Immunotherapy and Biomarkers 7

Co-authors: Sacha Gnjatic Lloyd J. Old Gerd Ritter Achim A. Jungbluth Jedd D. Wolchok Eric W. Hoffman Nasser K. Altorki Stephanie Terzulli
Journals: Proceedings of the National Academy of Sciences (6 papers)PLoS ONE (4 papers)Clinical Cancer Research (2 papers)Blood (2 papers)Journal of Neuroimmunology (2 papers)
Partner nations: United States Germany Switzerland

In The Last Decade

Erika Ritter

37 papers receiving 2.0k citations

Hit Papers

align trajectories log scale

Integrated NY-ESO-1 antibody and CD8⁺T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab 2011 · 254 citations

Peers

Countries citing papers authored by Erika Ritter

Since Specialization

Citations

This map shows the geographic impact of Erika Ritter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Ritter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Ritter more than expected).

Fields of papers citing papers by Erika Ritter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika Ritter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Ritter. The network helps show where Erika Ritter may publish in the future.

Co-authors

The 25 scholars most cited alongside Erika Ritter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Erika Ritter Line = papers co-authored together Erika Ritter links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancer iScience ·Elizabeth Comen, Sadna Budhu, Yuval Elhanati, David B. Page, Teresa Rasalan-Ho, Erika Ritter, Phillip Wong, George Plitas, Sujata Patil, Edi Brogi, Maxine S. Jochelson, Yolanda Bryce, Stephen B. Solomon, Larry Norton, Taha Merghoub, Heather L. McArthur	2024	5
2	B-CAP (brentuximab vedotin, cyclophosphamide, doxorubicin and predniso(lo)Ne) in Older Patients with Advanced-Stage Hodgkin Lymphoma: Results of a Phase II Intergroup Trial By the German Hodgkin Study Group (GHSG) and the Nordic Lymphoma Group (NLG) Kölner Universitäts PublikationsServer (Universität zu Köln) ·Boris Boell, Alexander Fosså, Helen Goergen, Peter Kamper, Sirpa Leppä, Daniel Molin, Julia Meißner, Erika Ritter, Jacob Haaber Christensen, Martin Hutchings, Martin Fuchs, Andreas Engert, Peter Borchmann, German Hodgkin Study	2018	0
3	Protein Expression Analysis of Melanocyte Differentiation Antigen TRP-2 American Journal of Dermatopathology ·Francesca Avogadri, Sacha Gnjatic, Jodie Tassello, Denise Frosina, Nicole Hanson, Megan Laudenbach, Erika Ritter, Taha Merghoub, Klaus J. Busam, Achim A. Jungbluth	2016	10
4	Effect of Montanide and Poly-ICLC Adjuvant on Human Self/Tumor Antigen-Specific CD4+ T Cells in Phase I Overlapping Long Peptide Vaccine Trial Cancer Immunology Research ·Takemasa Tsuji, Paul Sabbatini, Achim A. Jungbluth, Erika Ritter, Linda Pan, Gerd Ritter, Luis Ferran, David R. Spriggs, Andres Μ. Salazar, Sacha Gnjatic	2013	52
5	Phase I Clinical Trial of Mixed Bacterial Vaccine (Coley's Toxins) in Patients with NY-ESO-1 Expressing Cancers: Immunological Effects and Clinical Activity Clinical Cancer Research ·Julia Karbach, Antje Neumann, Kathrin Brand, Claudia Wahle, Ekkehard Siegel, Markus Maeurer, Erika Ritter, Takamasa Tsuji, Sacha Gnjatic, Lloyd J. Old, Gerd Ritter, Elke Jäger	2012	79
6	NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer PLoS ONE ·Foluso O. Ademuyiwa, Wiam Bshara, Kristopher Attwood, Carl Morrison, Stephen B. Edge, Christine B. Ambrosone, Tracey L. O’Connor, Ellis Levine, Anthony Miliotto, Erika Ritter, Gerd Ritter, Sacha Gnjatic, Kunle Odunsi	2012	75
7	Cancer/testis antigens expression and autologous serological response in a set of Brazilian non-Hodgkin’s lymphoma patients Cancer Immunology Immunotherapy ·Riguel Jun Inaoka, Achim A. Jungbluth, Sacha Gnjatic, Erika Ritter, Nicole Hanson, Denise Frosina, Jodie Tassello, Leina Yukari Etto, Adriana Bruscato Bortoluzzo, Antônio Corrêa Alves, Gisele W. B. Colleoni	2012	14
8	Integrated NY-ESO-1 antibody and CD8⁺T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab Proceedings of the National Academy of Sciences ·Jianda Yuan, Matthew Adamow, Brian Ginsberg, Teresa Rasalan, Erika Ritter, Humilidad F. Gallardo, Yinyan Xu, Evelina Pogoriler, Stephanie Terzulli, Deborah Kuk, Katherine S. Panageas, Gerd Ritter, Mario Sznol, Ruth Halaban, Achim A. Jungbluth, James P. Allison, Lloyd J. Old, Jedd D. Wolchok, Sacha Gnjatic Hit paper breakdown →	2011	254
9	Split T Cell Tolerance against a Self/Tumor Antigen: Spontaneous CD4+ but Not CD8+ T Cell Responses against p53 in Cancer Patients and Healthy Donors PLoS ONE ·Takemasa Tsuji, Junko Matsuzaki, Erika Ritter, Anthony Miliotto, Gerd Ritter, Kunle Odunsi, Lloyd J. Old, Sacha Gnjatic	2011	14
10	Alphavirus Replicon Particles Expressing TRP-2 Provide Potent Therapeutic Effect on Melanoma through Activation of Humoral and Cellular Immunity PLoS ONE ·Francesca Avogadri, Taha Merghoub, Maureen F. Maughan, Daniel Hirschhorn-Cymerman, J. Glenn Morris, Erika Ritter, Robert A. Olmsted, Alan N. Houghton, Jedd D. Wolchok	2010	53
11	Cancer-Testis Antigens and Immunosurveillance in Human Cutaneous Squamous Cell and Basal Cell Carcinomas Clinical Cancer Research ·Anne Walter, Marjam J. Barysch, Silvia Behnke, Piotr Dziunycz, Bruno Schmid, Erika Ritter, Sacha Gnjatic, Glen Kristiansen, Holger Moch, Alexander Knuth, Reinhard Dummer, Maries van den Broek	2010	53
12	Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arrays Journal of Immunological Methods ·Sacha Gnjatic, Colin Wheeler, Martin Ebner, Erika Ritter, Anne Murray, Nasser K. Altorki, Cathy A. Ferrara, Henry Hepburne-Scott, Sarah Joyce, Jens Koopman, Michael B. McAndrew, Nicholas Workman, Gerd Ritter, Rachel Fallon, Lloyd J. Old	2008	60
13	Expression and purification of the cancer antigen SSX2: A potential cancer vaccine Protein Expression and Purification ·Chung‐Jr Huang, Rishard H. Chen, Todd Vannelli, Frank Lee, Erika Ritter, Gerd Ritter, Lloyd J. Old, Carl A. Batt	2007	8
14	Vaccine-Induced CD4+ T Cell Responses to MAGE-3 Protein in Lung Cancer Patients The Journal of Immunology ·Djordje Atanackovic, Nasser K. Altorki, Elisabeth Stockert, Barbara Williamson, Achim A. Jungbluth, Erika Ritter, Darren Santiago, Cathy A. Ferrara, Mitsutoshi Matsuo, Annamalai Selvakumar, Bo Dupont, Yao-Tseng Chen, Eric W. Hoffman, Gerd Ritter, Lloyd J. Old, Sacha Gnjatic	2004	148
15	Monitoring CD4+ T cell responses against viral and tumor antigens using T cells as novel target APC Journal of Immunological Methods ·Djordje Atanackovic, Mitsutoshi Matsuo, Erika Ritter, Gail P. Mazzara, Gerd Ritter, Elke Jäger, Alexander Knuth, Lloyd J. Old, Sacha Gnjatic	2003	42
16	Does intravenous ondansetron affect gastric emptying of a solid meal, gastric electrical activity or blood hormone levels in healthy volunteers? Alimentary Pharmacology & Therapeutics ·Peter Netzer, C. Gaia, Steven Lourens, P.U. Reber, Stephan M. Wildi, U. Noelpp, Erika Ritter, H. Ledermann, D. Lüscher, Lilian Varga, J Kinser, Markus W. Büchler, U Scheurer	2002	22
17	Deactivation of thalamocortical activity is responsible for suppression of parkinsonian tremor by thalamic stimulation: a 99mTc-ECD SPECT study Clinical Neurology and Neurosurgery ·Johannes P. Wielepp, Jean‐Marc Burgunder, Thomas Pohle, Erika Ritter, J Kinser, Joachim K. Krauss	2001	18
18	Specificity and structure of murine monoclonal antibodies against GM1 ganglioside Journal of Neuroimmunology ·Nan‐ping Weng, Erika Ritter, Eftal Yücel, Dai Zhang, Gerd Ritter, D MARCUS	1994	11
19	Cerebrovascular and neurological disorders associated with antiphospolipid antibodies in CSF and serum Journal of the Neurological Sciences ·Paolo Gallo, S. Sivieri, A.M. Ferrarini, Bruno Giometto, Amelia Ruffatti, Erika Ritter, Carlo Chizzolini, B. Tavolato	1994	13
20	The morphological effects of chenodeoxycholic acid on human gastric mucosa. PubMed ·Sawyer Wr, Erika Ritter, Faloon Ww	1984	1

About Erika Ritter

Erika Ritter is a scholar working on Immunology, Oncology, Gastroenterology, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 38 papers that have together received 2.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (25 papers), T-cell and B-cell Immunology (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Glycosylation and Glycoproteins Research (7 papers), Immune Cell Function and Interaction (7 papers), Cancer Immunotherapy and Biomarkers (7 papers), vaccines and immunoinformatics approaches (7 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Immunology (1.4k citations), Oncology (1.1k citations), Biotechnology (113 citations), Molecular Biology (722 citations) and Radiology, Nuclear Medicine and Imaging (197 citations). Erika Ritter has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Sacha Gnjatic, Lloyd J. Old, Gerd Ritter, Achim A. Jungbluth, Jedd D. Wolchok, Eric W. Hoffman, Nasser K. Altorki, Stephanie Terzulli, James P. Allison and Jianda Yuan. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE, Clinical Cancer Research, Blood and Journal of Neuroimmunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact